The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

A high red blood cell count can occur for many reasons, including excessive cell production, changes in blood volume, or underlying medical conditions. Sometimes, the cause is unknown. Erythrocytes, ...

For patients with a rare type of blood cancer, treatment might finally be coming out of the Dark Ages. People with the chronic condition polycythemia vera make too many red blood cells, thickening ...

MPNs involve overproduction of blood cells, while MDS results in poorly formed cells, affecting blood cell function and counts. Diagnosis requires blood tests, bone marrow biopsy, and genetic testing ...

The only cure for painful sickle cell disease today is a bone marrow transplant. But soon there may be a new cure that attacks the disorder at its genetic source. On Tuesday, advisers to the Food and ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

FILE - This July 2019 image provided by the Sarah Cannon Research Institute shows Victoria Gray on her infusion day during a gene editing trial for sickle cell disease at the Sarah Cannon Research ...

The term “rare blood disorders” describes less common conditions that affect blood cells’ ability to function correctly. Myeloproliferative disorders and lymphoproliferative disorders are two types of ...

Juvenile Myelomonocytic Leukemia, or JMML, is a rare and aggressive childhood blood cancer that mostly affects kids under ...

Represents a supplementary FDA approval for Omisirge. DUBLIN, IE AND LONDON, UK / ACCESS Newswire / December 5, 2025 / Ayrmid Ltd. ("Ayrmid" or the "Company"), the parent company ...